CIAM
NGNE icon

Caitong International Asset Management’s Neurogene NGNE Stock Holding History

Caitong International Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-405
Closed -$6.05K – 2324
2025
Q2 		$6.05K Buy
405
+151
+59% +$2.37K ﹤0.01% 937
2025
Q1 		$2.97K Buy
254
+159
+167% +$2.76K ﹤0.01% 1197
2024
Q4 		$2.17K Buy
+95
New +$3.54K ﹤0.01% 1161

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caitong International Asset Management's NGNE Position: Q3 2025 in Review

Caitong International Asset Management sold out of Neurogene (NGNE) in Q3 2025, closing a stake of 405 shares — an estimated $6.05K sold.

Caitong International Asset Management first reported a position in NGNE in Q4 2024 and held it in 3 quarters. The position peaked at $6.05K in Q2 2025. 88 funds tracked by Wall St. Rank hold NGNE as of Q3 2025.

  • Caitong International Asset Management reported no remaining Neurogene position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 405 Neurogene shares in Q3 2025, an estimated $6.05K.
  • Caitong International Asset Management first reported a position in Neurogene in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Neurogene position peaked at $6.05K in Q2 2025.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.